Respiratory Aspiration  >>  fluticasone propionate HFA  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fluticasone propionate HFA / Generic mfg.
NCT02266927: A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2)

Completed
1
28
Europe
Flovent HFA, OPTINOSE™ FLUTICASONE
Optinose US Inc.
Mild to Moderate Asthma
03/15
04/15

Download Options